Exact Mass: 459.0954

Exact Mass Matches: 459.0954

Found 90 metabolites which its exact mass value is equals to given mass value 459.0954, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 4-sulfate

2-[3-acetamido-2-hydroxy-6-(hydroxymethyl)-5-sulfooxyoxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

4-Deoxy-beta-D-gluc-4-enuronosyl-(1,3)-N-acetyl-D-galactosamine 6-sulfate

2-[3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate

6,7-dihydroxy-3-(2-hydroxyphenyl)-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-tetrahydro-3aH-pyrano[2,3-d][1,3]oxazol-2-one

C19H25NO12 (459.1377)

Trace metabolite of corn. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. 1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate is found in cereals and cereal products. Trace metabolite of corn.

4-Methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-glucopyranoside

N-{4,5-dihydroxy-2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]-6-[(sulphooxy)methyl]oxan-3-yl}ethanimidic acid

C18H21NO11S (459.0835)

Analogue A

5-Chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboximidate

C23H23Cl2N3O3 (459.1116)

Mivebresib

N-[4-(2,4-difluorophenoxy)-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}phenyl]ethane-1-sulfonamide

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

Phe-Trp-OH

(S)-2-(3-(benzyloxy)-4-nitrobenzamido)-3-(1H-indol-3-yl)propanoic acid

C25H21N3O6 (459.143)

1-(2-Hydroxyphenylamino)-1-deoxy-b-D-gentiobioside 1,2-carbamate

6,7-dihydroxy-3-(2-hydroxyphenyl)-5-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-hexahydro-2H-pyrano[2,3-d][1,3]oxazol-2-one

C19H25NO12 (459.1377)

2-Propanol,1-[(6-chloro-2-methoxy-9-acridinyl)amino]-3-(diethylamino)-, hydrochloride(1:2)

C21H28Cl3N3O2 (459.1247)

FR 122047 hydrochloride

C23H26ClN3O3S (459.1383)

terbium acetylacetonate

C15H24O6Tb (459.0826)

Benzyl N-N-phenylmethoxycarbonyl-N

C18H16F3N3O6S (459.0712)

(2E,5E)-3-benzyl-2-(4-methoxy phenylimino)-5-(3-methylbenzo[d]thiazol-2(3H)-ylidene)thiazolidin-4-one

C25H21N3O2S2 (459.1075)

[4-(2,4-difluorophenyl)-2-[(4-methoxyphenyl)carbamoyl]phenyl] benzoate

C27H19F2NO4 (459.1282)

(+/-)-n,n-dimethyl-1-(2-diphenylphosphino)ferrocenylethylamine monohydrate

C26H30FeNOP (459.1414)

Flurazepam hydrochloride

Flurazepam dihydrochloride

C21H25Cl3FN3O (459.1047)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

Aluminum triquinolin-8-olate

C27H18AlN3O3 (459.1164)

Disperse Red 220

C26H22ClN3O3 (459.135)

Ticolubant

C23H19Cl2NO3S (459.0463)

C308 - Immunotherapeutic Agent

Nitrocycline

C21H21N3O9 (459.1278)

C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

4-methyl-N-[2-[(5-oxo-2,3-dihydrothiazolo[2,3-b]quinazolin-3-yl)methylthio]phenyl]benzamide

C25H21N3O2S2 (459.1075)

N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-5-oxo-6-thiazolo[3,2-a]pyrimidinecarboxamide

C19H17N5O5S2 (459.0671)

Prinomastat hydrochloride

C18H22ClN3O5S2 (459.0689)

7n-Methyl-8-hydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)

(C8-R)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

(C8-S)-Hydantocidin 5-phosphate

C13H22N3O13P (459.089)

Mivebresib

C22H19F2N3O4S (459.1064)

C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor

wogonin 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of wogonin 7-O-beta-D-glucuronide.

CDP-N-methylethanolamine(1-)

C12H21N4O11P2- (459.0682)

oroxylin A 7-O-beta-D-glucuronate

C22H19O11- (459.0927)

The monocarboxylic acid anion that is the conjugate base of oroxylin A 7-O-beta-D-glucuronide.

5-O-[N-(L-Aspartyl)sulfamoyl]adenosine

C14H17N7O9S-2 (459.0808)

4-deoxy-Delta(4)-beta-D-GlcpA2S-(1->3)-beta-D-GalpNAc

C14H21NO14S (459.0683)

Aspartyl-phosphonate-adenosine

C15H20N6O9P- (459.1029)

(2R,3R,4S)-2-[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(sulfooxymethyl)oxan-4-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

(2R,3R,4S)-2-[(2R,3R,4R,5R)-5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-3,4-dihydroxy-3,4-dihydro-2H-pyran-6-carboxylic acid

C14H21NO14S (459.0683)

5-chloro-N-[3-(2-chlorophenyl)-1-(4-hydroxypiperidin-1-yl)-1-oxopropan-2-yl]-1H-indole-2-carboxamide

C23H23Cl2N3O3 (459.1116)

[[5-(4-Amino-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-oxidophosphoryl] 2-(methylazaniumyl)ethyl phosphate

C12H21N4O11P2- (459.0682)

4-(2,6-Difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperidine

C19H19F2NO6S2 (459.0622)

(6R,7R)-3-[(4-carbamoyl-1-pyridin-1-iumyl)methyl]-8-oxo-7-[(1-oxo-2-thiophen-2-ylethyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C20H19N4O5S2+ (459.0797)

5-[(2,4-dichlorophenoxy)methyl]-N-[1-[(2-fluorophenyl)methyl]-3-pyrazolyl]-2-furancarboxamide

C22H16Cl2FN3O3 (459.0553)

(Z)-4-(1,3-benzothiazol-2-yl)-5-[4-(N-methylanilino)-3-nitrophenyl]-4-pentenoic acid

C25H21N3O4S (459.1253)

N-{2-[4-(4-chlorobenzoyl)-1-piperazinyl]phenyl}-1-benzofuran-2-carboxamide

C26H22ClN3O3 (459.135)

(2E)-3-[5-(4-bromophenyl)furan-2-yl]-2-cyano-N-[2-(1H-indol-3-yl)ethyl]prop-2-enamide

C24H18BrN3O2 (459.0582)

3-(4-Butyl-3-oxo-2-quinoxalinyl)propanoic acid [2-(3-chloro-4-fluoroanilino)-2-oxoethyl] ester

C23H23ClFN3O4 (459.1361)

4-[(2-Methoxyphenyl)-methylsulfamoyl]benzoic acid [2-[(5-methyl-3-isoxazolyl)amino]-2-oxoethyl] ester

C21H21N3O7S (459.11)

5-chloro-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-3-methyl-2-benzofurancarboxamide

C21H18ClN3O5S (459.0656)

1-(4-amino-1,2,5-oxadiazol-3-yl)-N-[(E)-(2-bromophenyl)methylidene]-5-(pyrrolidin-1-ylmethyl)-1H-1,2,3-triazole-4-carbohydrazide

C17H18BrN9O2 (459.0767)

prunetin-5-O-beta-D-glucuronide

C22H19O11- (459.0927)

prunetin-4-O-beta-D-glucuronide

C22H19O11- (459.0927)

beta-D-4-deoxy-Delta(4)-GlcpA-(1->3)-beta-D-GalpNAc6S

C14H21NO14S (459.0683)

(6R,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6S,7S,8R)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

(6R,7R,8S)-7-(4-bromophenyl)-8-(hydroxymethyl)-N-(4-methoxyphenyl)-2-oxo-1,4-diazabicyclo[4.2.0]octane-4-carboxamide

C21H22BrN3O4 (459.0794)

Farnesyl triphosphate(3-)

C15H26O10P3-3 (459.0739)

2-(Acetylamino)-2-Deoxy-3-O-(4-Deoxy-Alpha-L-Threo-Hex-4-Enopyranuronosyl)-4-O-Sulfo-Beta-D-Galactopyranose

C14H21NO14S (459.0683)

(5-fluoro-2,4-dioxo-1H-pyrimidin-6-yl) 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylate

C21H19F2N5O5 (459.1354)

(S)-2-(4-Chlorophenyl)-2-Pyridin-3-Yl-1-[4-[4-(Trifluoromethyl)phenyl]piperazin-1-Yl]ethanone

C24H21ClF3N3O (459.1325)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-4-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

2-acetamido-2-deoxy-3-O-(4-deoxy-alpha-L-threo-hex-4-enopyranosyluronic acid)-6-O-sulfo-D-galactopyranose

C14H21NO14S (459.0683)

7-methyl-7,8-dihydroguanosine-5-diphosphate

C11H19N5O11P2 (459.0556)

A purine ribonucleoside 5-diphosphate having 7-methyl-7,8-dihydroguanine as the nucleobase.

1-(2-Hydroxyphenylamino)-1-deoxy-beta-D-gentiobioside 1,2-carbamate

C19H25NO12 (459.1377)

KG5

C20H16F3N7OS (459.1089)

KG5 is an orally active dual PDGFRβ and B-Raf allosteric inhibitor. KG5 also inhibits Flt3, KIT and c-Raf. KG5 has anticancer, antiangiogenic activities[1].

(4r,5s,6r)-4,5-dihydroxy-6-[(s)-[(3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

12-(3,4-dihydroxyphenyl)-7,8,16,17-tetrahydroxy-4-oxa-1-azapentacyclo[11.8.0.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁹]henicosa-5,7,9,12,14,16,18,20-octaen-3-one

C25H17NO8 (459.0954)

2,8-dichloro-1-[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-methoxyoxan-2-yl]-5-hydroxy-6-methylchromeno[2,3-b]pyrrol-4-one

C19H19Cl2NO8 (459.0488)

(4s,5s,6s)-4,5-dihydroxy-6-[(r)-[(2s,3s,4r,5r)-4-hydroxy-5-(4-hydroxy-2-oxopyrimidin-1-yl)-3-methoxyoxolan-2-yl](c-hydroxycarbonimidoyl)methoxy]-5,6-dihydro-4h-pyran-2-carboxylic acid

C17H21N3O12 (459.1125)

1-(2-hydroxyphenylamino)-1-deoxy-β-gentio-bioside 1,2-carbamate

C19H25NO12 (459.1377)

{"Ingredient_id": "HBIN000886","Ingredient_name": "1-(2-hydroxyphenylamino)-1-deoxy-\u03b2-gentio-bioside 1,2-carbamate","Alias": "NA","Ingredient_formula": "C19H25NO12","Ingredient_Smile": "C1=CC=C(C(=C1)N2C3C(C(C(C(O3)COC4C(C(C(C(O4)CO)O)O)O)O)O)OC2=O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10608","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}